Targeting aging and age-related diseases with vaccines
Abstract
Aging is a major risk factor for numerous chronic diseases. Vaccination offers a promising strategy to combat these age-related diseases by targeting specific antigens and inducing immune responses. Here, we provide a comprehensive overview of recent advances in vaccine-based interventions targeting these diseases, including Alzheimer's disease, type II diabetes, hypertension, abdominal aortic aneurysm, atherosclerosis, osteoarthritis, fibrosis and cancer, summarizing current approaches for identifying disease-associated antigens and inducing immune responses against these targets. Further, we reflect on the recent development of vaccines targeting senescent cells, as a strategy for more broadly targeting underlying causes of aging and associated pathologies. In addition to highlighting recent progress in these areas, we discuss important next steps to advance the therapeutic potential of these vaccines, including improving and robustly demonstrating efficacy in human clinical trials, as well as rigorously evaluating the safety and long-term effects of these vaccine strategies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several clinical investigations focusing on Aβ have produced contradictory findings, casting doubt on the veracity of the amyloid theory in general.
“Several clinical investigations focusing on Aβ have produced contradictory findings, casting doubt on the veracity of the amyloid theory in general.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [93]
While lowering Aβ levels can decrease cognitive deterioration, not all patients will definitely see improved clinical outcomes from this strategy.
“While lowering Aβ levels can decrease cognitive deterioration, not all patients will definitely see improved clinical outcomes from this strategy, according to certain research [86,93].”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [93]
The citation lists haven’t been fetched yet
References 227 · Cited by 66
- Authors
- Wu, R., Sun, F., Zhang, W., Ren, J., & Liu, G.-H.
- Affiliations
- Chinese Academy of Sciences (CN)
- Duke Medical Center (US)
- Capital Medical University (CN)
- Corresponding author
- Zhang, Weiqi
- Ren, Jie
- Liu, Guang-Hui
- Venue
- Nature Aging
- Published
- 2024-04-15
- Volume
- 4
- Issue
- 4
- Pages
- 464-482
- ISSN
- 2662-8465 (ISSN-L)
- OpenAlex
- W4394812925
- Cited by
- 66
- References
- 227
- Citations by year
- 2026: 15 · 2025: 33 · 2024: 18
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Aging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Keywords
- age-related diseases, senescent cells, Alzheimer's disease, type 2 diabetes, hypertension, abdominal aortic aneurysm, atherosclerosis, osteoarthritis, fibrosis, cancer vaccines, immunostimulation, vaccine safety and efficacy
- MeSH terms
- Aging, Diabetes Mellitus, Type 2, Humans, Neoplasms, Vaccination, Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review